Stay tuned and follow the latest
developments and news in Molecular Oncology.
Genekor participated again this year in the European Human Genetics Conference 2024 held in Berlin, where Dr. Konstantinos Agiannitopoulos, Molecular Biologist, Ph.D and Group Leader of Genekor’s Hereditary Cancer Group, […]
Read More
Breast cancer remains the most common type of cancer among women worldwide and remains the leading cause of death. Neuroendocrine breast cancer (NBC), a rare subtype that occurs in less […]
Read More
There are rapid developments in the field of early diagnosis of many cancers. Pioneering molecular tests, which also use AI, are now available in our country and can change the […]
Read More
Genekor Medical S.A. actively participated in the 2-day Scientific Meeting on Cardiac Amyloidosis and Genetic Cardiopathies on April 19 and 20 at the Cotsen Auditorium of the American School of […]
Read More
We feel joy and pride that “The Smile of the Child” was awarded for its humanitarian work and its contribution to the health sector. Our partnership began in 2022, with […]
Read More
Our recent study ” Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice” aimed to determine how often patients with tumors with MSI-high are […]
Read More
Genekor team has joined the event organized by the Romanian Lynch Syndrome Society dedicated to improving the lives of oncology patients. Through this collaboration, we aim to bring real solutions […]
Read More
Genekor supports the efforts of the Hellenic National Anti-Epilepsy Association (E.E.E.E.E.) and the Panhellenic Scientific Association against Epilepsy (P.E.S.E.) for the information and awareness of epilepsy. We believe in equal […]
Read More
Genekor, with a focus on the prevention and early diagnosis of genetic diseases, offers free genetic counseling to all examinees who wish, before, during and/or after genetic testing for hereditary […]
Read More